BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32808495)

  • 1. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.
    Casarin J; Bogani G; Piovano E; Falcone F; Ferrari F; Odicino F; Puppo A; Bonfiglio F; Donadello N; Pinelli C; LaganĂ  AS; Ditto A; Malzoni M; Greggi S; Raspagliesi F; Ghezzi F
    J Gynecol Oncol; 2020 Sep; 31(5):e64. PubMed ID: 32808495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
    Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
    Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study.
    Unsal M; Kilic C; Cakir C; Kilic F; Ersak B; Karakas S; Tokgozoglu N; Varli B; Oktar O; Kimyon Comert G; Ozdemir IA; Boran N; Toptas T; Ureyen I; Korkmaz V; Taskin S; Moraloglu Tekin O; Ustun Y; Tasci T; Ortac F; Turan T
    J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
    JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
    Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density.
    Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H
    Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.
    Li H; Xie X; Liu Y; Huang X; Lin H; Li J; Lin Z
    Eur J Surg Oncol; 2020 Jul; 46(7):1339-1346. PubMed ID: 32402510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
    Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
    Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
    Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M
    Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
    Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.